-
Join 357 other subscribers
Blogroll
HIV/AIDS networks
Links
- bilaterals.org
- Fix the Patent Laws!
- FTA Malaysia
- HAI Europe
- Health Action International (HAI)
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS
- MSF Access Campaign
- Patent Opposition Database
- Public Citizen
- Stop EU-India FTA
- Stop Peru FTA
- Third World Network
- Treatment Action Group
- UAEM Europe
- UAEM evidence collection
- Universities Allied for Essential Medicines (UAEM)
Archives
-
Recent Posts
- Clamour against United Kingdom’s free-trade negotiator
- India, EU conclude another round of talks for proposed trade agreement
- Next round of India, UK talks for free trade agreement to be held in March
- ‘Playing with the lives of HIV patients’: Drug shortages force many to change medication regime
- Pfizer’s Covid pill Paxlovid gets WHO’s approval. All you need to know
Categories
Category Archives: Antibiotics
The Covid treatment pill is here – and big pharma will ultimately decide who gets it
Experts are predicting demand for life-saving antiviral drugs will rapidly outpace supply. Like the vaccine, the poorest countries will be left until last Source: The Guardian Covid-19 has quietly become the gift that keeps on giving for big pharma. The … Continue reading
Posted in Access to Medecines, Access to Medicins, Antibiotics, COVID-19, Diseases/Therapies, Drugs, Generics, Vaccines
Tagged COVID19, India, Medicine, Medicines
Leave a comment
Pandemic puts a global spotlight on IP, as countries step-up efforts to be heard
Source: The Hindu Business Line Experts call for more from India, a key voice in the past Last Friday, the African Union marked a milestone as technology to make mRNA vaccines now prepares to roll-out from the world’s first mRNA … Continue reading
Posted in Antibiotics, COVID-19, Diseases/Therapies, Organizations, Right to Health, Vaccines, WHO
Tagged Generics, India, Medicines
Leave a comment
India’s antimicrobial resistance and how to solve this problem
Powerful medications are slowly becoming ineffective for many Indians due to misuse of antibiotics Source: FreePressJournal A recent ICMR report has left healthcare providers, patients, and infection control experts worried about the rising Antimicrobial Resistance in India. The report says … Continue reading
Posted in Access to Medicins, Antibiotics, COVID-19, Diseases/Therapies, Drugs, Generics, India, Quality, Vaccines
Tagged COVID19, Generics, India, Medicine, Medicines, therapeutics
Leave a comment
AMR mitigation must top pharma industry’s agenda
To deal with this threat, the pharma sector must adopt environmentally sustainable production and supply chain measures. Source: TheHinduBusinessLine The economic and social consequences of the Covid-19 pandemic have reiterated the destructive capacity of untreatable infectious diseases. While we actively … Continue reading
Posted in Access to Medicins, Antibiotics, COVID-19, Diseases/Therapies, Drugs, Generics, Right to Health, Vaccines
Tagged COVID19, Generics, Health, India, therapeutics, Vaccines
Leave a comment
Antimicrobial resistance is rising in India, says ICMR report.
Source: TheTimes Of India MUMBAI: More than 50% of the ICU patients battling a type of the Pneumonia caused by bacteria Klebsiella Pneumoniae will not respond to powerful antibiotics called carbapenem. Another antibiotics, imipenem, will not affect a mutated form of … Continue reading
Posted in Access to Medecines, Access to Medicins, Antibiotics, COVID-19, Diseases/Therapies, Drugs, Generics, India, Vaccines
Tagged COVID19, Generics, India, Medicine, therapeutics
Leave a comment
WHO Essential Medicines Review : Cancer Drugs, Insulin Analogues Draw Controversy
Source :Health Policy Watch 15th April, 2019 Expanding access to costly cancer treatments and the high price of new generation insulin formulas were among the controversial topics of debate today as the WHO Expert Committee on the Selection and Use … Continue reading
Posted in Antibiotics, Cancer, WHO
Leave a comment
Sanofi faces criticism at lung conference
Treatment Action Campaign; December 4, 2015. CApe Town – Activists at the 46th Union World Conference on Lung Health demanded that pharmaceutical company Sanofi be held accountable for endangering failing to provide life-saving products to people and children living with TB and … Continue reading
Posted in Antibiotics, Tuberculosis (TB)
Leave a comment
First new TB drugs in half a century reach just 2% of people who need them
MSF; December 3, 2015. Cape Town – Nearly three years since the first of two new tuberculosis (TB) medicines became available, the drugs remain out of reach for people who need them, with just two percent of people eligible for these treatments … Continue reading
Posted in Antibiotics, Pricing, Tuberculosis (TB)
Leave a comment
Tackling Antimicrobial Resistance Is an Area BRIC Countries Can Lead the World – They Must Take This Opportunity
Huffington Post; November 12, 2015. Brazil, India, Russia and China have gone through a period of rapid economic development, making them important global players in the 21st century. However, they are also the countries that might be affected most severely by growing antimicrobial … Continue reading
Posted in Antibiotics, BRICS, Innovation
Leave a comment
Pay big pharma to solve antibiotics crisis, says UK government review
The Guardian; Pharmaceutical companies should be given cash incentives of up to $3bn to find and develop new antibiotics desperately needed to keep infections at bay, according to a UK government review. Jim O’Neill, the economist and former chair of … Continue reading
Posted in Antibiotics, Delinkage, Innovation
Leave a comment
Don't trade our lives away 